Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-06-05

Clinical Trial Update: ANGIOTENSIN AGENTS AND REDUCTION OF THE PRESCRIPTION OF ANTIDEPRESSANT DRUGS: A RETROSPECTIVE COHORT STUDY USING REAL-WORLD DATA

View source ↗

Summary

A retrospective real-world study examined whether angiotensin agents (ACE inhibitors and ARBs) influence antidepressant prescribing. The trial status is withdra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACE inhibitors
  • ARB (angiotensin II receptor blockers) (Angiotensin II receptor blockers)

Snippet

Sponsor: Sebastian Videla | Conditions: ACE Inhibitors, ARB | Status: WITHDRAWN